Financhill
Back

Ionis Pharmaceuticals 10K Form

Sell
37

IONS
Ionis Pharmaceuticals

Last Price:
37.31
Seasonality Move:
4.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive IONS News And Ratings

See the #1 stock for the next 7 days that we like better than IONS

IONS Financial Statistics

Sales & Book Value

Annual Sales: $787.65M
Cash Flow: $-155.67M
Price / Cash Flow: 0
Annual Sales: $2.03
Price / Book: 18.37

Profitability

EPS (TTM): -2.67000
Net Income (TTM): $-384.77M
Gross Margin: $778.51M
Return on Equity: -100.54%
Return on Assets: -13.23%

Ionis Pharmaceuticals Earnings Forecast

Key Ionis Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 34 years for IONS is 98.84%.
  • The Selling, General & Administrative Expenses for IONS have been equal to 29.53% of Gross Profit Margin.
  • The Research & Development expenses have been 114.22% of Revenue.
  • The Interest Expense is -20.64% of Operating Income.
  • The Net Earning history of IONS is -46.50% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 16 years.

Ionis Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IONS
CUSIP: 462222
Website: ionispharma.com

Debt

Debt-to-Equity Ratio: 4.3
Current Ratio: 7.37
Quick Ratio: 6.75

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IONS Technical Analysis vs Fundamental Analysis

Sell
37
Ionis Pharmaceuticals (IONS) is a Sell

Is Ionis Pharmaceuticals a Buy or a Sell?